An NCI-designated Comprehensive Cancer Center, affiliated with the University of Pittsburgh School of Medicine
Research
Researchers from UPMC Hillman Cancer Center and colleagues published their results from the CAMILLA trial showing that combining cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer is a promising treatment, potentially expanding treatment options for patients with microsatellite stable…
Please join UPMC Hillman Cancer Center in welcoming Saad Sheikh, MD, effective February 1, 2024. Dr. Sheikh is an assistant professor in the Department of Radiation Oncology at the University of Pittsburgh and a member of the Genome Stability Program…
Please join UPMC Hillman Cancer Center in welcoming Tatiana Moiseeva, PhD, effective February 1, 2024. She is an assistant professor in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh and a member of the Genome Stability…
It is common practice for clinicians to administer granulocyte colony-stimulating factor (G-CSF) — a growth factor used to replenish white blood cell counts — during chemotherapy, but what are its effects on overall survival in patients with pancreatic cancer? …
As part of our strategic planning and our evolving plan to enhance diversity, we are realigning our leadership to better serve our community. We have consolidated our three population-based Associate Director (AD) roles into two: AD for Community Outreach and…
The 35th Annual UPMC Hillman Cancer Center Scientific Retreat was held September 26-27, 2023. The event consisted of lectures, including the Director’s Annual State of the Cancer Center, a shark tank-style minnow competition, and poster presentations. Featured Lectures Ronald B.…
After a national search and with approval of the External Advisory Board, UPMC Hillman Cancer Center is pleased to announce Jason J. Luke, MD, FACP, has been appointed the Associate Director (AD) of Clinical Research. Dr. Luke served as the…
The University of Pittsburgh was awarded a five-year grant from the National Institutes of Health (NIH) to support an Ovarian Cancer Specialized Program of Research Excellence (SPORE). The award is led by Ronald Buckanovich, MD, PhD, and Robert Edwards, MD. Dr. Buckanovich is a professor…
After a national search, we are pleased to announce Theresa (Tess) Cummings, RN, DBA, CCRP as the new Associate Director for Research Administration at UPMC Hillman Cancer Center, effective November 1, 2023. In this role, Dr. Cummings is a member…
Clarivate™ has named their list of Highly Cited Researchers for 2023 — an elite group that demonstrates significant and broad influence in their field of research. Each researcher selected has authored multiple Highly Cited Papers™, which rank in the top…
